Association of ITGAV polymorphisms and risk of rheumatoid arthritis: evidence from a meta-analysis

References

• Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet. 2001 Sep 15;358(9285):903–911.
   PubMed Web of Science ®Google Scholar
• MacGregor AJ, Snieder H, Rigby AS, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheumatism. 2000 Jan;43(1):30–37.
   PubMed Web of Science ®Google Scholar
• Brookes AJ. The essence of SNPs. Gene. 1999 Jul 8;234(2):177–186.
   PubMed Web of Science ®Google Scholar
• Garcia de la Pena M, Mendez Cruz R, Garrido Guerrero E, et al. Polymorphism rs2275913 of interleukin-17A is related to more intensive therapy with disease-modifying anti rheumatic drugs in Mexican patients with rheumatoid arthritis. Acta Reumatol Port. 2017 Apr-Jun;42(2):155–161.
   PubMed Web of Science ®Google Scholar
• Zhang C, Jiao S, Li T, et al. Relationship between polymorphisms in −572G/C interleukin 6 promoter gene polymorphisms (rs1800796) and risk of rheumatoid arthritis: A meta-analysis. Int J Rheum Dis. 2019 Nov;29.
   Web of Science ®Google Scholar
• Paradowska-Gorycka A, Pawlik A, Romanowska-Prochnicka K, et al. Relationship between VEGF gene polymorphisms and serum VEGF protein levels in patients with rheumatoid arthritis. PloS One. 2016;11(8):e0160769.
   PubMed Web of Science ®Google Scholar
• Hussein YM, Mohamed RH, El-Shahawy EE, et al. Interaction between TGF-beta1 (869C/T) polymorphism and biochemical risk factor for prediction of disease progression in rheumatoid arthritis. Gene. 2014 Feb 25;536(2):393–397.
   PubMed Web of Science ®Google Scholar
• Lin X, Zhang Y, Chen Q. FCRL3 gene polymorphisms as risk factors for rheumatoid arthritis. Hum Immunol. 2016 Feb;77(2):223–229.
   PubMed Web of Science ®Google Scholar
• Wu X, Yang HJ, Jung Kim M, et al. Association between PTPN22-1123G/C and susceptibility to rheumatoid arthritis: A systematic review and meta-analysis. Int J Rheum Dis. 2019 May;22(5):769–780.
   PubMed Web of Science ®Google Scholar
• Lowin T, Straub RH. Integrins and their ligands in rheumatoid arthritis. Arthritis Res Ther. 2011;13(5):244.
   PubMed Web of Science ®Google Scholar
• Eliceiri BP, Cheresh DA. The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Invest. 1999 May;103(9):1227–1230.
   PubMed Web of Science ®Google Scholar
• Barczyk M, Carracedo S, Gullberg D. Integrins. Cell Tissue Res. 2010 Jan;339(1):269–280.
   PubMed Web of Science ®Google Scholar
• Jacq L, Garnier S, Dieude P, et al. The ITGAV rs3738919-C allele is associated with rheumatoid arthritis in the European Caucasian population: a family-based study. Arthritis Res Ther. 2007;9(4):R63.
   PubMed Web of Science ®Google Scholar
• Fallah AA, Morovvati S, Ahmadi K, et al. No association between ITGAV rs3738919 and rs3768777 polymorphisms and rheumatoid arthritis susceptibility in Iranian population. Labiumsmedizin-J Lab Med. 2016 Dec;40(6):413–417.
   Web of Science ®Google Scholar
• Hollis-Moffatt JE, Rowley KA, Phipps-Green AJ, et al. The ITGAV rs3738919 variant and susceptibility to rheumatoid arthritis in four Caucasian sample sets. Arthritis Res Ther. 2009;11(5):5.
   Web of Science ®Google Scholar
• Iikuni N, Kobayashi S, Ikari K, et al. ITGAV polymorphism and disease susceptibility in a Japanese rheumatoid arthritis population. Arthritis Res Ther. 2007;9(5):5.
   Web of Science ®Google Scholar
• Jacq L, Garnier S, Dieude P, et al. The ITGAV rs3738919-C allele is associated with rheumatoid arthritis in the European Caucasian population: a family-based study. Arthritis Res Ther. 2007;9(4):4.
   Web of Science ®Google Scholar
• Koca SS, Kara M, Ozgen M, et al. The rs3768777-G allele of ITGAV gene is associated with rheumatoid arthritis. Rheumatol Int. 2014 May;34(5):693–698.
   PubMed Web of Science ®Google Scholar
• Shakiba E, Tavilani H, Goodarzi MT, et al. The ITGAV-rs3911238 polymorphism is associated with disease activity in rheumatoid arthritis. Iran J Allergy Asthma Immunol. 2014 Oct;13(5):356–363.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009 Jul 21;6(7):e1000097.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheumatism. 1988 Mar;31(3):315–324.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheumatism. 2010 Sep;62(9):2569–2581.
   PubMed Web of Science ®Google Scholar
• Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
   Google Scholar
• Thakkinstian A, McElduff P, D’Este C, et al. A method for meta-analysis of molecular association studies. Stat Med. 2005 May 15;24(9):1291–1306.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. Bmj. 2003 Sep 6;327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials. 1986 Sep;7(3):177–188.
   PubMedGoogle Scholar
• Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 Apr;22(4):719–748.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. Bmj. 1997 Sep 13;315(7109):629–634.
   PubMed Web of Science ®Google Scholar
• Wellcome Trust Case Control C. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007 Jun 7;447(7145): 661–678.
   PubMed Web of Science ®Google Scholar
• Stupack DG. Integrins as a distinct subtype of dependence receptors. Cell Death Differ. 2005 Aug;12(8):1021–1030.
   PubMed Web of Science ®Google Scholar
• Wilder RL. Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases. Ann Rheum Dis. 2002 Nov;61(Suppl 2):ii96–9.
   PubMedGoogle Scholar
• Pandya NM, Dhalla NS, Santani DD. Angiogenesis–a new target for future therapy. Vascul Pharmacol. 2006 May;44(5):265–274.
   PubMed Web of Science ®Google Scholar
• Storgard CM, Stupack DG, Jonczyk A, et al. Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist. J Clin Invest. 1999 Jan;103(1):47–54.
   PubMed Web of Science ®Google Scholar
• Arshadi D, Nikbin B, Shakiba Y, et al. Plasma level of neopterin as a marker of disease activity in treated rheumatoid arthritis patients: association with gender, disease activity and anti-CCP antibody. Int Immunopharmacol. 2013 Nov;17(3):763–767.
   PubMed Web of Science ®Google Scholar